In the Spotlight
Read the CCR Translation- Ushering in Liquid Biopsy for the Microsatellite Status: Advantages and Caveats, about related articles by Georgiadis, et al., and Willis, et al.
Read "Distinct Roles for BET Family Members in Estrogen Receptor α Enhancer Function and Gene Regulation in Breast Cancer Cells" in MCR. Murakami and colleagues define a precise role for BRD3 in estrogen receptor (ER)-positive breast cancer cells, revealing BRD3 as a critical mediator of the ER-dependent transcriptional program in ER+ breast cancers, and highlight its potential as a target to disrupt pathologic estrogen signaling at the transcription level. Read more in MCR’s December issue!
New collections! Check out the Cancer Immunology Research collections: Immunotherapy Trials and Tribulations and Toolbox: Signatures and Cells. Complimentary access is available for a limited time!
Just published to coincide with its presentation at the International Conference on Molecular Targets and Cancer Therapeutics, read The KRASG12C Inhibitor, MRTX849, Provides Insight Toward Therapeutic Susceptibility of KRAS Mutant Cancers in Mouse Models and Patients, in Cancer Discovery!
Keep up with “what’s new” by following the AACR Journals on Twitter:
@BCD_AACR: Blood Cancer Discovery
@CD_AACR: Cancer Discovery
@CEBP_AACR: Cancer Epidemiology, Biomarkers & Prevention
@CIR_AACR: Cancer Immunology Research
@CAPR_AACR: Cancer Prevention Research
@CR_AACR: Cancer Research
@CCR_AACR: Clinical Cancer Research
@MCR_AACR: Molecular Cancer Research
@MCT_AACR: Molecular Cancer Therapeutics
